CAR-T cells are specialized immune cells genetically modified to recognize and attack cancer cells. Researchers at Nagoya ...

AnaptysBio offers significant upside, with fair value estimates nearly double its current market cap if RA approval is ...

Sustainable fuels for cruise ships are still not widely available, but preparation for that day is well underway.

A new understanding of how tumours exploit our nervous system is leading to new ways to treat cancer using familiar drugs ...

Cellnex’s long-term contracts and share buybacks support a bullish outlook for the stock. Read more on what investors should ...

The dual-targeting CAR T-cell therapy KITE-363 showed positive response rates and manageable side effects in relapsed or ...

A growing number of college students are trading in their smartphones for what’s now considered trendy hardware: flip phones.

Also in the Cleveland Heights blotter, police arrested for disorderly conduct a man whose dislike of his neighbor's dog got ...

A Falmouth teen, Jayden Wilsey, is the first to receive gene therapy to treat sickle cell at Boston Children's Hospital.

Tarlatamab prolonged both overall and progression-free survival in the treatment of small cell lung cancer, backing it as a ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...